Schlitt et al.
JOCFeatured Article
interest in modified nucleosides stems from research on DNA
adduction by phenolic toxins that undergo metabolic activa-
tion to form phenoxyl radical intermediates that can attach
covalently to the C8-site of 20-deoxyguanosine (dG).7 Due to
the ambident (O- vs C-attack) reactivity of phenoxyl radicals
both O- and C-linked adducts are produced, as exemplified by
O-PCP-8-dG (Figure 1) derived from pentachlorophenol
(PCP)8 and C-OTA-8-dG derived from the mycotoxin ochra-
toxin A (OTA).9 Other phenolic C-adducts shown in Figure 1
that are likely formed from phenoxyl radical intermediates
include those derived from nickel(II)-salen complexes, such
as the metallopeptide-PNA bioconjugate (C-Ni(II)salen-8-
dG)10 that have been isolated and characterized by the
Burrows laboratory. The hydroquinone adduct C-(3,4-EQ)-
8-dG is formed from reductive activation of 3,4-estrone
quinone (3,4-EQ) that yields semiquinone radical intermedi-
ates.11 These phenolic C-adducts are structurally related to a
familyof C8-aryladducts. Examples include6-BP-8-dG thatis
formed from the polycyclic aromatic hydrocarbon (PAH)
benzo[a]pyrene (BP)12 and N-Ac-ABA-8-dG that is derived
from the powerful PAH mutagen 3-nitrobenzanthrone
(NBA).13 Oxidation of PAHs by CYP peroxidase to yield
PAH radical cations facilitates C8-aryl adduct formation.14
Carcinogenic arylhydrazines that produce aryl radical inter-
mediates also form C8-aryl adducts that contain phenyl (Ph)
groups bearing various para (p) substituents (i.e., X-Ph-8-dG,
X = COOH, CH2OCH3, CH2OH, Figure 1).15
6-BP-8-dG from the enzymatic digest of the precipitated
DNA, while the supernatant contained roughly the same
concentration of the corresponding 6-BP-8-G adduct.12a
Significant levels of abasic site formation has also been
reported for arylhydrazine treatment of DNA.15e Akanni
and Abul-Hajj proposed that C-(3,4-EQ)-8-dG (Figure 1) is
formed as an intermediate prior to the loss of the deoxyribose
sugar to afford C-(3,4-EQ)-8-G.11c Overall, these results
have led to proposals that formation of abasic sites following
C8-aryl adduct formation may contribute to the carcinogeni-
city of PAHs14 and arylhydrazines.15e
For unmodified dG it is well-known that development of a
positive charge at N7, either through protonation16 (pKa for
protonated dG is 2.3417) or alkylation,18 accelerates the rate
of hydrolysis. Acid-catalyzed hydrolysis of dG proceeds via
an A-1 mechanism involving equilibrium protonation (at N7
for the monocation and N3 for the dication), which precedes
the unimolecular rate-limiting cleavage of the C-N bond.16
19
Substitution of dG with electron-withdrawing NO2 and
20
SO2CH3 C8-substituents greatly accelerates hydrolysis,
while electron-donating NH221 and OCH322 C8-substituents
decreases the rate of hydrolysis. Interestingly, bulky elec-
tron-donating arylamino23 and dimethylamino21 C8-substit-
uents accelerate hydrolysis compared to the unmodified base
despite their electron-donating character. This has been
ascribed to release of steric strain upon removal of the
deoxyribose moiety.23,24
A common property of C8-aryl adduction is the accom-
paniment of abasic site formation in studies carried out at
physiological pH. Treatment of DNA with BP in aqueous
media with horseradish peroxidase (HRP)/HOOH afforded
Because the loss of sugar from C8-aryl adducts at neutral
pH was unexpected,12,15 we sought to determine rates of
hydrolysis for the C8-Ph-dG adducts 1-3c (Figure 1) that
bear para (p)-(2a-2e) and ortho (o)-substituents (3a-3c) of
varying electronic and steric properties. These adducts are
readily prepared using palladium-catalyzed Suzuki cross-
coupling reactions25 and include the known arylhydrazine-
derived phenyl adduct 1,15 the isomeric C-phenolic adducts
2a and 3a formed from reactions of DNA with mutagenic
diazoquinones,26 and others serving as structural models for
C8-aryl adducts in general. To determine how the C8-aryl
moiety contributes to sugar loss for adducts 1-3c, we have
measured rates of hydrolysis in aqueous solutions of varying
acidity and employed density functional theory (DFT) cal-
culations to assist interpretation of the kinetic experiments.
Our observations have led to the development of a new
rationale for the noted tendency of abasic site formation to
(7) (a) McLaughlin, C. K.; Lantero, D. R.; Manderville, R. A. J. Phys.
Chem. A. 2006, 110, 6224–6230. (b) Sun, K. M.; McLaughlin, C. K.; Lantero,
D. R.; Manderville, R. A. J. Am. Chem. Soc. 2007, 129, 1894–1895. (c)
Weishar, J. L.; McLaughlin, C. K.; Baker, M.; Gabryelski, W.; Manderville,
R. A. Org. Lett. 2008, 10, 1839–1842.
(8) (a) Dai, J.; Wright, M. W.; Manderville, R. A. Chem. Res. Toxicol.
2003, 16, 817–821. (b) Dai, J.; Sloat, A. L.; Wright, M. W.; Manderville, R. A.
Chem. Res. Toxicol. 2005, 18, 771–779.
(9) (a) Dai, J.; Wright, M. W.; Manderville, R. A. J. Am. Chem. Soc. 2003,
125, 3716–3717. (b) Dai, J.; Park, G.; Perry, J. L.; Il’ichev, Y. V.; Bow, D. A.
J.; Pritchard, J. B.; Pfohl-Leszkowicz, A.; Manderville, R. A.; Simon, J. D.
Acc. Chem. Res. 2004, 37, 874–881. (c) Faucet, V.; Pfohl-Leszkowicz, A.;
Dai, J.; Castegnaro, M.; Manderville, R. A. Chem. Res. Toxicol. 2004, 17,
1289–1296.
(10) (a) Stemmler, A. J.; Burrows, C. J. J. Am. Chem. Soc. 1999, 121,
6956–6957. (b) Kornyushyna, O.; Stemmler, A. J.; Graybosch, D. M.;
Bergenthal, I.; Burrows, C, J. Bioconjugate Chem. 2005, 16, 178–183.
(11) (a) Abul-Hajj, Y. J.; Tabakovic, K.; Tabakovic, I. J. Am. Chem. Soc.
1995, 117, 6144–6145. (b) Akanni, A.; Abul-Hajj, Y. J. Chem. Res. Toxicol.
1997, 10, 760–766. (c) Akanni, A.; Abul-Hajj, Y. J. Chem. Res. Toxicol. 1999,
12, 1247–1253.
(16) (a) Zoltewicz, D.; Clark, D. F.; Sharpless, T. W.; Grahe, G. J. Am.
Chem. Soc. 1970, 92, 1741–1750. (b) Hevesi, L.; Wolfson-Davidson, E.;
Nagy, J. B.; Nagy, O. B.; Bruylants, A. J. Am. Chem. Soc. 1972, 94, 4715–
4720. (c) Zoltewicz, J. A.; Clark, D. F. J. Org. Chem. 1972, 37, 1193–1197.
(17) Da Costa, C. P.; Sigel, H. Inorg. Chem. 2003, 42, 3475–3482.
(18) Gates, K. S.; Nooner, T.; Dutta, S. Chem. Res. Toxicol. 2004, 17,
839–856.
(19) (a) Yermilov, V.; Rubio, J.; Ohshima, H. FEBS Lett. 1995, 376, 207–
210. (b) Tretyakova, N. Y.; Burney, S.; Pamir, B.; Wishnok, J. S.; Dedon, P.
C.; Wogan, G. N.; Tannenbaum, S. R. Mutat. Res. 2000, 447, 287–303.
(12) (a) Rogan, E. G.; Cavalieri, E. L.; Tibbels, S. R.; Cremonesi, P.;
Warner, C. D.; Nagel, D. L.; Tomer, K. B.; Cerny, R. L.; Gross, M. L. J. Am.
Chem. Soc. 1988, 110, 4023–4029. (b) Cavalieri, E. L.; Rogan, E. G.; Li, K.-
M.; Todorovic, R.; Ariese, F.; Jankowiak, R.; Grubor, N.; Small, G. J. Chem.
Res. Toxicol. 2005, 18, 976–983.
(13) Enya, T.; Kawanishi, M.; Suzuki, H.; Matsui, S.; Hisamatsu, Y.
Chem. Res. Toxicol. 1998, 11, 1460–1467.
ꢀ
(14) (a) Cavalieri, E.; Rogan, E. Environ. Health Persp. 1985, 64, 69–84.
(b) Cavalieri, E. L.; Rogan, E. G. Pharmac. Ther. 1992, 55, 183–199. (c)
Chakravarti, D.; Pelling, J. C.; Cavalieri, E. L.; Rogan, E. G. Proc. Natl.
Acad. Sci. U.S.A. 1995, 92, 10422–10426.
(15) (a) Lawson, T.; Gannett, P. M.; Yau, W.-M.; Dalal, N. S.; Toth, B. J.
Agric. Food Chem. 1995, 43, 2627–2635. (b) Hiramoto, K.; Kaku, M.;
Sueyoshi, A.; Fujise, M.; Kikugawa, K. Chem. Res. Toxicol. 1995, 8, 356–
362. (c) Gannett, P. M.; Lawson, T.; Miller, M.; Thakkar, D. D.; Lord, J. W.;
Yau, W.-M.; Toth, B. Chem.-Biol. Interact 1996, 101, 1–25. (d) Kohda, K.;
Tsunomoto, H.; Kasamatsu, T.; Sawamura, F.; Terashima, I.; Shibutani, S.
Chem. Res. Toxicol. 1997, 10, 1351–1358. (e) Gannett, P. M.; Powell, J. H.;
Rao, R.; Shi, X.; Lawson, T.; Kolar, C.; Toth, B. Chem. Res. Toxicol. 1999,
12, 297–304.
(20) Laayoun, A.; Decout, J.-L.; Lhomme, J. Tetrahedron Lett. 1994, 35,
4989–4990.
(21) Jordan, F.; Niv, H. Nucleic Acids Res. 1982, 10, 4339–4349.
(22) Garrett, E. R.; Mehta, P. J. J. Am. Chem. Soc. 1972, 94, 8532–8541.
(23) Novak, M.; Ruenz, M.; Kazerani, S.; Toth, K.; Nguyen, T.-M.;
Heinrich, B. J. Org. Chem. 2002, 67, 2303–2308.
€
(24) Hovinen, J.; Glemarec, C.; Sandstrom, A.; Sund, C.; Chattopad-
hyaya, J. Tetrahedron 1991, 47, 4693–4708.
(25) (a) Western, E. C.; Daft, J. R.; Johnson, E. M. II; Gannett, P. M.;
Shaughnessy, K. H. J. Org. Chem. 2003, 68, 6767–6774. (b) Western, E. C.;
Shaughnessy, K. H. J. Org. Chem. 2005, 70, 6378–6388. (c) Dai, Q.; Xu, D.;
Lim, K.; Harvey, R. G. J. Org. Chem. 2007, 72, 4856–4863.
(26) Kikugawa, K.; Kato, T.; Kojima, K. Mutat. Res. 1992, 268, 65–75.
5794 J. Org. Chem. Vol. 74, No. 16, 2009